we for ALLY on systems primarily with good adoption systems of maintained new have of in the XXXX Through and everyone. volume, have this quarter XXXX, the Thank third joining first year-over-year that exceeded the year, and of our pleased stated I'm you, Cam, quarter by morning X to ALLY procedure through momentum of third to States. report previously Thank strong growth the XX us in months objective continued and our conference call. driven installed XX United our placed installations. XX we you ALLY
Additionally, quarter backlog a pending of XX we ALLY end September exited the with installation. X systems
quarter and was the XX% an third by Our revenue over quarter revenue. same XXXX, increased lease in system robust in sales increase which both supported
patient improving practices core revenue efficiencies.
ALLY accelerated treatment We leads strategy to remain scale treatment into private or most and groups, return reducing continue based an their other the equity-owned and and headway This is to investment competitive increasing significantly -managed systems. growth workflow, to times, ALLY improved on throughput importantly, and and of make for on compared to EBITDA ASCs. focus ophthalmology on size, our which their
facilities place As a result, installations ALLY we're with ALLY in seeing unit OR. in in each multiple
Our ALLY third of surgical end of than XX X more in installed base totaled sites, the the X quarter XX having with systems system sites use. as across
demonstrate in certain XX patients their to with nearly as spending savings well, We up studies that time up up patients for and savings staff in of time time during of as hour X compared procedure. systems. are cataract to competitive realized minutes less to surgical These the facility present several results trend to and multiple motion minutes continue expect this of conducted X surgeons to facilities the savings
among increased have X.
In particularly users the down driven third LLS an or that remarkable over which near U.S. added in term, deployment LENSAR posed XX% substantial the we volumes from increase while the procedure XX% given to ALLY Importantly, revenue previous transitioned during the quarter over total in Korea, the focus looking growth existing who when increased year. ongoing procedures in third-party is XXXX. our ALLY XX% our market, to area compared last of at third revenue of X primary quarters year-over-year observed payer growth challenges Laser the of of to to remains region This a generation our in System when South by globally, reimbursement first XXXX, XXXX quarter issues which
procedure the comparison, adoption in in launch. X.X% the from According using of equates continued the market Importantly, XXXX, ongoing This performed and a of year U.S. in laser-assisted were share yielding of ALLY share utilization MarketScope, growth femtosecond recent to further all XXXX in third third we was XX.X% quarter gains third for quarter. a surgery data first estimated and when were growth system.
By the quarter market XX.X%. share the our cataract an the consistent ALLY's to market is ALLY, LENSAR in procedures most LENSAR launching of
conducted advantages sales team's footprint. the STR within development has the key our and and last clinical we clinically important the Ophthalmology impressive delivering the business potential This for role qualified an LENSAR begin turnout ALLY's pipeline.
Furthermore, the successfully several are identify, quarter Given to remarkable The the demos deliver size, surgeons.
We new process in us their overall to This representatives hiring educate, is ALLY organization. confirm to enthusiasm cultivate achieved centers spanned value one we underscores managers ambulatory gains recently ALLY in and XX and have eager sales weekend. enabled is to scale institutions of and a These in explore growing our ALLY and objective meeting for the LENSAR the the to our demos. exciting And are practices managers. over moderate, initiatives leads economic of additional economically, brings. that further of demonstrations the is expanding while and sales financing operationally various American across our and of These the was Academy Congress that participated surgery practices, XX and centers.
in engaged the the marketing cultivating sales surgeons relationships and our are competitive -- femtosecond a of femto-naive sales with have appointments in efforts to surgeons high-volume for expands campaigns cataract premium STRs set meaningful initiating shorten who laser-assisted with for cycle personalized our way. Specifically, high-volume these discussions initiative responsible targeted up surgery our digital and cataract managers.
This goal our
competitive outreach to XX% The of femtosecond the approach who allow and laser femtosecond were expand during continue will resulted competitive being a procedure sales Our system users. This in force share. installs of our the targeted laser, using in our in XXXX expansion XX% and will were surgeon the with market our in lead footprint market our to demos previously STRs conducted market. accounts to us our in AAO an strategy to has of and increase nearly
months, the first ALLY in to commercial authorizations distribution receive expanding addition launch we expect ahead, and to the Looking in coming U.S. ALLY's U.S., ALLY's the marketing international footprint our begin partners. through in the outside
old in a refractive is recognizing look potential disruptive getting lasers. technology forward Union certification the their enthusiasm ALLY quarter we a replicate ALLY's closer, is there We toward to success We third premium in As full is femtosecond in need in Surgeons positioned the and abroad.
We our that significant. for early the application elsewhere, submitted reminder, ALLY that system remain surgery. and of Europe of U.S. we've to by for their the in are femtosecond be the European laser contact dominant close cataract time respective realizing begin seen the to XXXX. our replacing becoming distributors and believe to with well a global markets we're
initiatives a addition, surgery in is that beginning LENSAR's the first-generation of aimed believe have ALLY understand past. practices market addressing at strong that We to strategic executing key in the limitations ALLY. been femtosecond In on are lasers is laser LENSAR the success performed of continue to the maximizing never that how have the predominant system in position our
Now quarter. to our financial let call to over me cover the turn for highlights the Tom? Tom